Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose inhaled PF-00610355 in moderate COPD
2008-001396-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing PF-00610355 sequence with Placebo sequence (2 arms). Primary endpoints: PF-00610355 pharmacokinetics (AUCinf), PF-00610355 pharmacokinetics (AUClast) and 5 more. Started Jul 2008; status: completed.
02
Drugs
PF-00610355
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-001396-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001396-30.